Abnormal SPP1 expression is associated with a variety of skeletal disorders, and clinical studies have shown that serum SPP1 levels are positively correlated with the severity of osteoporosis and can be used as a biomarker for the early diagnosis of osteoporosis in postmenopausal women [34]. The gene discussed is SPP1; the disease is osteoporosis.